| Title | Date | Quest Diagnostics Extends Endocrine Diagnostic Menu with New Congenital Adrenal Hyperplasia (CAH) Steroid Screening Panels| Features newborn screening panel that measures all 13 CAH-associated steroids by tandem mass spectrometry in a single analysis
MADISON, N.J., May 17, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women. The p... |
| 05/17/12 | Quest Diagnostics Reminds Women to Make Their Health a Priority During National Women's Health Week| Company Distributes 10,000 Vouchers for Free Wellness Screenings in May in Support of American Cancer Society Choose You® Women's Health Movement
MADISON, N.J., May 16, 2012 /PRNewswire/ -- This week, National Women's Health Week, Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, joins the American Cancer Society Choose You® movement and the U.S. Department of Health and Human Services' (HHS) Office on Women's Health (OWH) in remind... |
| 05/16/12 | Quest Diagnostics Declares Quarterly Cash Dividend|
MADISON, N.J., May 11, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.17 per share, payable on July 18, 2012, to shareholders of record of Quest Diagnostics common stock on July 3, 2012.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services... |
| 05/11/12 | Quest Diagnostics Sponsors American Cancer Society Choose You® Women's Health Movement| Company Offers 10,000 Vouchers for Free Wellness Screenings as National Presenting Sponsor
NEW YORK, May 1, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced its national presenting sponsorship of the American Cancer Society Choose You® movement, which encourages women nationwide to live well today and stay well tomorrow. In support of the Choose You movement and in recognition of National Women'... |
| 05/01/12 |
|
